rs145786819

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2

The NM_014324.6(AMACR):​c.554T>C​(p.Val185Ala) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,613,938 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00083 ( 1 hom., cov: 33)
Exomes š‘“: 0.0011 ( 3 hom. )

Consequence

AMACR
NM_014324.6 missense, splice_region

Scores

2
8
9
Splicing: ADA: 0.2734
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:1

Conservation

PhyloP100: 9.06
Variant links:
Genes affected
AMACR (HGNC:451): (alpha-methylacyl-CoA racemase) This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]
C1QTNF3-AMACR (HGNC:49198): (C1QTNF3-AMACR readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring C1q and tumor necrosis factor related protein 3 (C1QTNF3) and alpha-methylacyl-CoA racemase (AMACR) genes on chromosome 5. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus not likely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3941239).
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMACRNM_014324.6 linkc.554T>C p.Val185Ala missense_variant, splice_region_variant Exon 4 of 5 ENST00000335606.11 NP_055139.4 Q9UHK6-1
AMACRNM_001167595.2 linkc.554T>C p.Val185Ala missense_variant, splice_region_variant Exon 4 of 6 NP_001161067.1 Q9UHK6-5
AMACRNM_203382.3 linkc.393T>C p.Gly131Gly splice_region_variant, synonymous_variant Exon 3 of 4 NP_976316.1 Q9UHK6-4
C1QTNF3-AMACRNR_037951.1 linkn.910T>C splice_region_variant, non_coding_transcript_exon_variant Exon 8 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMACRENST00000335606.11 linkc.554T>C p.Val185Ala missense_variant, splice_region_variant Exon 4 of 5 1 NM_014324.6 ENSP00000334424.6 Q9UHK6-1
ENSG00000289791ENST00000382068.3 linkc.393T>C p.Gly131Gly splice_region_variant, synonymous_variant Exon 3 of 4 1 ENSP00000477108.1 V9GYU9
C1QTNF3-AMACRENST00000382079.3 linkn.835T>C splice_region_variant, non_coding_transcript_exon_variant Exon 8 of 9 2 ENSP00000371511.3 E9PGA6

Frequencies

GnomAD3 genomes
AF:
0.000841
AC:
128
AN:
152184
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000459
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00116
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.000947
AC:
238
AN:
251326
Hom.:
1
AF XY:
0.00105
AC XY:
142
AN XY:
135836
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.000723
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00150
Gnomad FIN exome
AF:
0.000693
Gnomad NFE exome
AF:
0.00121
Gnomad OTH exome
AF:
0.000979
GnomAD4 exome
AF:
0.00114
AC:
1664
AN:
1461636
Hom.:
3
Cov.:
33
AF XY:
0.00118
AC XY:
858
AN XY:
727150
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.000984
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00150
Gnomad4 FIN exome
AF:
0.000506
Gnomad4 NFE exome
AF:
0.00125
Gnomad4 OTH exome
AF:
0.000994
GnomAD4 genome
AF:
0.000827
AC:
126
AN:
152302
Hom.:
1
Cov.:
33
AF XY:
0.000658
AC XY:
49
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.000457
Gnomad4 AMR
AF:
0.00118
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000829
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.00116
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000872
Hom.:
0
Bravo
AF:
0.000945
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000914
AC:
111
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000872
EpiControl
AF:
0.00130

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:7Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:4Benign:1
May 01, 2016
CeGaT Center for Human Genetics Tuebingen
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 21, 2017
Eurofins Ntd Llc (ga)
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 29, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 14, 2019
Mayo Clinic Laboratories, Mayo Clinic
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 30, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Alpha-methylacyl-CoA racemase deficiency Uncertain:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 185 of the AMACR protein (p.Val185Ala). This variant is present in population databases (rs145786819, gnomAD 0.2%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with clinical features of AMACR-related conditions (PMID: 20818383, 25133958). ClinVar contains an entry for this variant (Variation ID: 235439). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

AMACR-related disorder Uncertain:1
Mar 27, 2024
PreventionGenetics, part of Exact Sciences
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

The AMACR c.554T>C variant is predicted to result in the amino acid substitution p.Val185Ala. This variant was reported in an individual with complex I deficiency and an individual with ataxia (Table S2, Calvo et al. 2010. PubMed ID: 20818383; Table 2, Fogel et al. 2014. PubMed ID: 25133958). This variant is reported in 0.15% of alleles in individuals of South Asian descent in gnomAD, including a homozygous observation. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.037
T
BayesDel_noAF
Pathogenic
0.15
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.19
T;.;T;T
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
D;D;D;D
M_CAP
Benign
0.036
D
MetaRNN
Benign
0.39
T;T;T;T
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
2.0
M;M;.;.
PrimateAI
Uncertain
0.53
T
PROVEAN
Uncertain
-2.7
D;D;.;.
REVEL
Uncertain
0.62
Sift
Benign
0.069
T;T;.;.
Sift4G
Uncertain
0.054
T;D;D;D
Polyphen
0.43
B;.;.;.
Vest4
0.82
MVP
0.63
MPC
0.31
ClinPred
0.038
T
GERP RS
5.5
Varity_R
0.55
gMVP
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.27
dbscSNV1_RF
Benign
0.40
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145786819; hg19: chr5-33998931; API